Compare Grab Holdings Ltd. (GRAB) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Grab Holdings Ltd. vs Nuwellis Inc — how do they compare? Grab Holdings Ltd. trades at $3.13 (market cap $12.60B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Grab Holdings Ltd. is far larger — about 5727.3× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 87,608,440). Which is the better fit depends on your goals — on Pluang, investors hold Grab Holdings Ltd. for 94 Days and Nuwellis Inc for 26 Days on average.
| GRAB | NUWE | |
|---|---|---|
Market Cap | $12.60B | $2.20M |
Volume | 87,608,440 | 121,544 |
Sector | Technology | Health |
52-Week High | $6.17 | $146.65 |
52-Week Low | $2.80 | $0.68 |
Typical Hold Time | 94 Days | 26 Days |
Enterprise Value | $8.33B | -$1.52M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GRAB trades at $3.11, up 1.3% today, with a bearish technical signal but strong fundamentals including a 22% YoY revenue growth in Q2 2026 and a net income margin of 16.03%. Recent news highlights a $30 million CEO share purchase and the acquisition of a 60% stake in Atome Financial for $1.49 billion, signaling confidence and expansion in financial services.
The outlook is positive with robust earnings beats and a 91.67% analyst buy rating, though risks include high capital expenditure, regional regulatory challenges, and volatile cash flows. The stock's current valuation at a P/E of 28 reflects growth expectations amid competitive pressures.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Grab Holdings Ltd.
Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
